Approval · Notice of Compliance 1113 · 2000
AGGRENOX: Notice of Compliance 1113
Issued April 13, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1113
- Date
- April 13, 2000
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Antiplatelet agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGGRENOX | 02242119 | Cancelled Post Market |
Medicinal ingredients
- ACETYLSALICYLIC ACID 25 MG per CAP
- DIPYRIDAMOLE 200 MG per CAP